Abstract
troduct
I
on
.
An observational longitudinal study.
P
ur
P
ose
.
Assess the relationship between obstructive sleep apnoea
(OSA) and DR cross-sectionally and longitudinally.
M
ethods
.
Adults with Type 2 diabetes mellitus (T2DM), who were re
-
cruited from a hospital-based diabetes clinic in the UK. Patients with
pre-existing OSA, end-stage renal disease and non-diabetic retinopa
-
thy were excluded. OSA (apnoea hypopnea index
≥
5 events/hour)
was assessed by a single overnight home-based cardio-respiratory
study (Alice PDX, Philips Respironics, USA). DR was assessed us
-
ing retinal images between 2007 and 2012. Sight threatening diabetic
retinopathy (STDR) was defined as presence of pre-proliferative or
proliferative DR, maculopathy or photocoagulation. Advanced DR
was defined as pre-proliferative or proliferative DR.
r
esults
.
199 patients were included (57.3% (n=114) men, 47.7%
(n=95) White Europeans). STDR and OSA prevalence were 38.7%
(n=77) and 62.8% respectively.
A
t
b
A
sel
I
ne
.
STR prevalence was higher in patients with OSA
(OSA+) compared to those without OSA (OSA-) [48.8% n=61 vs.
21.6% n=16, p<0.001]. After adjustment for confounders, OSA
remained independently associated with STR (OR 3.7, 95% CI
1.6-8.9, p=0.006), maculopathy (OR 4.5, 95% CI 1.8-11.4, p=0.002)
and advanced DR (OR 3.9, 95% CI 1.02-15.3, p=0.047). Mild
and moderate to severe OSA were independently associated
with STR and maculopathy and only moderate to severe OSA
was associated with advanced DR following adjustment for con
-
founders.
l
ong
I
tud
I
n
A
lly
.
Over the follow-up period of (4.4±1 years), more OSA+
patients progressed from no or background DR to advanced DR
(15.3% (n=17) vs. 3% (n=2), p=0.01). OSA was an independent pre
-
dictor of advanced DR development after adjustment for confounders
(OR 6.6, 95% CI 1.2-35.1, p=0.03). OSA did not predict the develop
-
ment of maculopathy.
c
onclus
I
ons
.
OSA is independently associated with STR and predicts
the development of preproliferative and proliferative DR. Intervention
-
al studies are needed to assess the impact of OSA treatment on DR.
Original language | English |
---|---|
Pages (from-to) | 449 |
Number of pages | 1 |
Journal | European Journal of Ophthalmology |
Volume | 23 |
Issue number | 3 |
DOIs | |
Publication status | Published - 1 May 2013 |
Event | 23rd meeting of the European Association for the Study of Diabetic eye Complications - Barcellona, Spain Duration: 23 May 2013 → 25 May 2013 |
Bibliographical note
23rd Meeting of the European Association for the Study of DiabetesEye Complications Study Group (EASDec), Barcelona, Spain May 23–25, 2013